Menopause Hormone Therapy

If you have a uterus, estrogen taken without a progestogen raises the risk of endometrial (uterine lining) cancer, so progesterone or a progestin is added to protect the lining. Women who have had a hysterectomy usually do not need it for this reason. This is also why the boxed warning about endometrial cancer remains on systemic estrogen-alone products.

Some women report better sleep on oral micronized progesterone, which can be mildly sedating and is usually taken at bedtime. Research specifically on sleep is limited, and responses vary. A licensed provider can discuss whether it fits your situation.

It is not automatically ruled out, but timing matters: the FDA's updated labeling recommends starting systemic HRT within 10 years of menopause onset or before age 60, and The Menopause Society notes risks are greater when therapy starts later. Low-dose vaginal estrogen for dryness or urinary symptoms is a different situation, with very little absorbed into the bloodstream. A licensed provider can review your history to see what is appropriate.

There is no single cutoff for everyone; the FDA's updated labeling notes that timing and duration are decisions made between the prescriber and the patient. The Menopause Society recommends reviewing benefits and risks regularly, at least once a year. Your licensed provider will revisit your plan at follow-ups.

Many women notice changes in hot flashes and night sweats within a few weeks, while sleep, mood and vaginal symptoms may take longer, sometimes around three months. Responses vary, and dose or form adjustments are common early on. Stay in touch with your licensed provider so your plan can be adjusted if needed.

Talk to your licensed provider before changing anything, because the dose, form or timing often needs adjusting and some symptoms may have other causes. Do not change your dose on your own. Message your care team or book a follow-up to review your plan.

Research has not shown that hormone therapy itself causes weight gain; the weight and belly fat changes many women notice in midlife are linked to aging and the menopause transition. Some women notice temporary bloating when starting. If weight is a concern, raise it in your visit so your licensed provider can look at the whole picture.

Low-dose vaginal estrogen acts mainly where it is applied, with very little reaching the bloodstream, which is why The Menopause Society supported removing its boxed warning. It is used for vaginal dryness, painful sex and some urinary symptoms. A licensed provider can tell you whether it is appropriate, including if you have a history of breast cancer.

It depends on the regimen: some schedules cause a monthly withdrawal bleed, while continuous regimens aim for no bleeding after an adjustment period, and spotting is common in the first few months. Report heavy bleeding, bleeding that returns after months without it, or any bleeding after menopause to your licensed provider, because it needs evaluation.

Hormone therapy reduces bone loss and fracture risk, but it is not recommended to prevent heart disease or dementia. The Menopause Society notes the benefit-risk balance is most favorable for women under 60 or within 10 years of menopause. A licensed provider can discuss bone health and other options with you.

There are non-hormonal prescription options for hot flashes, including certain antidepressants and newer medicines designed for vasomotor symptoms, plus approaches like cognitive behavioral therapy. The Menopause Society reviews the evidence for these options in its nonhormone therapy guidance. A licensed provider can help you compare them.

It depends on whether your ovaries were removed and on your symptoms; women without a uterus can often use estrogen alone, without a progestogen. If your hysterectomy was for uterine cancer, hormone therapy needs specialist input. A licensed provider will review your surgical history at your visit.